Managing abnormal blood lipids - A collaborative approach

被引：148

作者：

Fletcher, B ^{[1
]}

Berra, K ^{[1
]}

Ades, P ^{[1
]}

Braun, LT ^{[1
]}

Burke, LE ^{[1
]}

Durstine, JL ^{[1
]}

Fair, JM ^{[1
]}

Fletcher, GF ^{[1
]}

Goff, D ^{[1
]}

Hayman, LL ^{[1
]}

Hiatt, WR ^{[1
]}

Miller, NH ^{[1
]}

Krauss, R ^{[1
]}

Kris-Etherton, P ^{[1
]}

Stone, N ^{[1
]}

Wilterdink, J ^{[1
]}

Winston, M ^{[1
]}

机构：

[1] Amer Heart Assoc, Dallas, TX 75231 USA

来源：

CIRCULATION | 2005年 / 112卷 / 20期

关键词：

AHA Scientific Statements; lipids; risk factors; cholesterol; prevention;

D O I：

10.1161/CIRCULATIONAHA.105.169180

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Current data and guidelines recommend treating abnormal blood lipids (ABL) to goal. This is a complex process and requires involvement from various healthcare professionals with a wide range of expertise. The model of a multidisciplinary case management approach for patients with ABL is well documented and described. This collaborative approach encompasses primary and secondary prevention across the lifespan, incorporates nutritional and exercise management as a significant component, defines the importance and indications for pharmacological therapy, and emphasizes the importance of adherence. Use of this collaborative approach for the treatment of ABL ultimately will improve cardiovascular and cerebrovascular morbidity and mortality. © 2005 American Heart Association, Inc.

引用

页码：3184 / 3209

页数：26

共 295 条

[1]

Medical progress: Cardiac rehabilitation and secondary prevention of coronary heart disease. [J].